{"transactions":[{"id":741729,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:20.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":77500,"derivative":{"exercise_price":6.61,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0001193125-26-267500","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526267500/ownership.xml","form_type":"4"}},{"id":743098,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-10T23:07:25.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":13300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":13300,"derivative":{"exercise_price":12.89,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":13300},"source":{"system":"sec-edgar","filing":"0001193125-26-266241","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312526266241/ownership.xml","form_type":"4"}},{"id":743097,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T23:07:25.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":9200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":41083,"source":{"system":"sec-edgar","filing":"0001193125-26-266241","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312526266241/ownership.xml","form_type":"4"}},{"id":1106287,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-18T20:07:28.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 11, 2025 with respect to 11,450 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":11450,"derivative":{"exercise_price":8.37,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":11450},"source":{"system":"sec-edgar","filing":"0000950170-25-087887","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025087887/ownership.xml","form_type":"4"}},{"id":1106286,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-18T20:07:28.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":31883,"source":{"system":"sec-edgar","filing":"0000950170-25-087887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025087887/ownership.xml","form_type":"4"}},{"id":1106345,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-18T20:05:04.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 12, 2025 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":77500,"derivative":{"exercise_price":4.58,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0000950170-25-087881","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025087881/ownership.xml","form_type":"4"}},{"id":1478962,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T20:21:03.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":11515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 12, 2024 with respect to 11,515 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":11515,"derivative":{"exercise_price":25.85,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":11515},"source":{"system":"sec-edgar","filing":"0000950170-24-073702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024073702/ownership.xml","form_type":"4"}},{"id":1478961,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T20:21:03.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":7737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":23883,"source":{"system":"sec-edgar","filing":"0000950170-24-073702","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024073702/ownership.xml","form_type":"4"}},{"id":1480771,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-06-13T20:13:52.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":34400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":34400,"derivative":{"exercise_price":7.51,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":34400},"source":{"system":"sec-edgar","filing":"0000950170-24-073013","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024073013/ownership.xml","form_type":"4"}},{"id":1852196,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:28:46.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":6473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 14, 2023 with respect to 6,473 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":6473,"derivative":{"exercise_price":45.2,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":6473},"source":{"system":"sec-edgar","filing":"0001209191-23-037892","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123037892/doc4.xml","form_type":"4"}},{"id":1852195,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:28:46.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":4425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":16146,"source":{"system":"sec-edgar","filing":"0001209191-23-037892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123037892/doc4.xml","form_type":"4"}},{"id":1862426,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-06-09T01:26:53.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":9650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2023 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":9650,"derivative":{"exercise_price":6.37,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":9650},"source":{"system":"sec-edgar","filing":"0000899243-23-015008","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924323015008/doc4.xml","form_type":"4"}},{"id":2085162,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-12-15T23:09:57.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":9650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 13, 2022 and vests in full on the one-year anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":9650,"derivative":{"exercise_price":6.47,"expiration_date":"2032-12-13","underlying":"Common Stock","underlying_shares":9650},"source":{"system":"sec-edgar","filing":"0000899243-22-038685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924322038685/doc4.xml","form_type":"4"}},{"id":2229945,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T22:40:57.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":7688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 14, 2022 with respect to 7,688 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":7688,"derivative":{"exercise_price":38.49,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":7688},"source":{"system":"sec-edgar","filing":"0001209191-22-037602","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122037602/doc4.xml","form_type":"4"}},{"id":2229944,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T22:40:57.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":5197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":11721,"source":{"system":"sec-edgar","filing":"0001209191-22-037602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122037602/doc4.xml","form_type":"4"}},{"id":2237813,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-06-09T21:10:48.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 7, 2022 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":51000,"derivative":{"exercise_price":0.625,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001209191-22-035459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122035459/doc4.xml","form_type":"4"}},{"id":2266455,"issuer":{"id":127212,"kind":"organization","name":"ASPENTECH Corp","symbol":"AZPN"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-05-18T16:45:10.000Z","date":"2022-05-16","kind":"disposition_to_issuer","acquired":false,"shares":1531,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. (\"AspenTech\"), Emerson Electric Co., Emersub CX, Inc.,  (\"New AspenTech\") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the \"Merger\").  Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each AspenTech stock option (\"AspenTech Stock Option\") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option (\"Converted Option\") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option granted at the exercise price of $129.50 was fully vested on the date of grant."}],"balance_after":0,"derivative":{"exercise_price":129.5,"expiration_date":"2031-08-31","underlying":"Common Stock","underlying_shares":1531},"source":{"system":"sec-edgar","filing":"0001127602-22-014973","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/929940/000112760222014973/form4.xml","form_type":"4"}},{"id":2266454,"issuer":{"id":127212,"kind":"organization","name":"ASPENTECH Corp","symbol":"AZPN"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-05-18T16:45:10.000Z","date":"2022-05-16","kind":"disposition_to_issuer","acquired":false,"shares":303,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. (\"AspenTech\"), Emerson Electric Co., Emersub CX, Inc.,  (\"New AspenTech\") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the \"Merger\").  Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each AspenTech stock option (\"AspenTech Stock Option\") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option (\"Converted Option\") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option granted at the exercise price of $130.51 was fully vested on the date of grant."}],"balance_after":0,"derivative":{"exercise_price":130.51,"expiration_date":"2030-12-27","underlying":"Common Stock","underlying_shares":303},"source":{"system":"sec-edgar","filing":"0001127602-22-014973","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/929940/000112760222014973/form4.xml","form_type":"4"}},{"id":2266453,"issuer":{"id":127212,"kind":"organization","name":"ASPENTECH Corp","symbol":"AZPN"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-05-18T16:45:10.000Z","date":"2022-05-16","kind":"disposition_to_issuer","acquired":false,"shares":1444,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. (\"AspenTech\"), Emerson Electric Co., Emersub CX, Inc.,  (\"New AspenTech\") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the \"Merger\").  Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each AspenTech stock option (\"AspenTech Stock Option\") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option (\"Converted Option\") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option granted at the exercise price of $133.20 was fully vested on the date of grant."}],"balance_after":0,"derivative":{"exercise_price":133.2,"expiration_date":"2029-09-02","underlying":"Common Stock","underlying_shares":1444},"source":{"system":"sec-edgar","filing":"0001127602-22-014973","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/929940/000112760222014973/form4.xml","form_type":"4"}},{"id":2266452,"issuer":{"id":127212,"kind":"organization","name":"ASPENTECH Corp","symbol":"AZPN"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-05-18T16:45:10.000Z","date":"2022-05-16","kind":"disposition_to_issuer","acquired":false,"shares":1684,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. (\"AspenTech\"), Emerson Electric Co., Emersub CX, Inc.,  (\"New AspenTech\") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the \"Merger\").  Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each AspenTech stock option (\"AspenTech Stock Option\") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option (\"Converted Option\") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One third of the option granted at the exercise price of $109.97 will vest on the first anniversary of the grant date and the remainder will vest in eight equal consecutive quarterly installments on the last business day of the quarter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":109.97,"expiration_date":"2029-04-16","underlying":"Common Stock","underlying_shares":1684},"source":{"system":"sec-edgar","filing":"0001127602-22-014973","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/929940/000112760222014973/form4.xml","form_type":"4"}},{"id":2266451,"issuer":{"id":127212,"kind":"organization","name":"ASPENTECH Corp","symbol":"AZPN"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-18T16:45:10.000Z","date":"2022-05-16","kind":"disposition_to_issuer","acquired":false,"shares":3465,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. (\"AspenTech\"), Emerson Electric Co., Emersub CX, Inc.,  (\"New AspenTech\") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the \"Merger\").  Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding share of the AspenTech common stock (other than certain excluded shares) automatically converted into the right to receive $87.69 in cash (the \"Cash Consideration\"), plus 0.42 of a validly issued, fully paid and nonassessable share of New AspenTech."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-22-014973","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/929940/000112760222014973/form4.xml","form_type":"4"}},{"id":2272560,"issuer":{"id":127212,"kind":"organization","name":"ASPENTECH Corp","symbol":"AZPN"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-13T16:59:49.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Aspen Technology, Inc. common stock. The Restricted Stock Units were fully vested on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Restricted Stock Units were received as a grant for no consideration."}],"balance_after":3465,"source":{"system":"sec-edgar","filing":"0001127602-22-014476","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/929940/000112760222014476/form4.xml","form_type":"4"}},{"id":2296972,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-04-15T00:44:38.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":2534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 23, 2021 with respect to 2,534 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":2534,"derivative":{"exercise_price":83.59,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":2534},"source":{"system":"sec-edgar","filing":"0000899243-22-014838","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000089924322014838/doc4a.xml","form_type":"4/A","original_submission_date":"2021-06-25"}},{"id":2296971,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-15T00:44:38.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":1569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":6524,"source":{"system":"sec-edgar","filing":"0000899243-22-014838","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000089924322014838/doc4a.xml","form_type":"4/A","original_submission_date":"2021-06-25"}},{"id":2580222,"issuer":{"id":127212,"kind":"organization","name":"ASPENTECH Corp","symbol":"AZPN"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-09-03T16:27:36.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":1531,"price":129.5,"value":198264.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option granted at the exercise price of $129.50 was fully vested on the date of grant."}],"balance_after":1531,"derivative":{"exercise_price":129.5,"exercise_date":"2021-09-01","expiration_date":"2031-08-31","underlying":"Common Stock","underlying_shares":1531},"source":{"system":"sec-edgar","filing":"0001127602-21-024890","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/929940/000112760221024890/form4.xml","form_type":"4"}},{"id":2580221,"issuer":{"id":127212,"kind":"organization","name":"ASPENTECH Corp","symbol":"AZPN"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-09-03T16:27:36.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Aspen Technology, Inc. common stock. The Restricted Stock Units were fully vested on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Restricted Stock Units were received as a grant for no consideration."}],"balance_after":2639,"source":{"system":"sec-edgar","filing":"0001127602-21-024890","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/929940/000112760221024890/form4.xml","form_type":"4"}},{"id":2654778,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-25T22:10:43.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":3382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 23, 2021 with respect to 3,382 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":3382,"derivative":{"exercise_price":83.59,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":3382},"source":{"system":"sec-edgar","filing":"0001209191-21-043381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919121043381/doc4.xml","form_type":"4"}},{"id":2654777,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-25T22:10:43.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":2094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":2094,"source":{"system":"sec-edgar","filing":"0001209191-21-043381","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919121043381/doc4.xml","form_type":"4"}},{"id":2750413,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-13T20:37:14.000Z","date":"2021-04-09","kind":"grant","acquired":true,"shares":7755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on April 9, 2021 with respect to 7,755 shares of Common Stock pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan, with 33 1/3% vesting on April 9, 2022 and the remaining 66 2/3% vesting in 8 substantially equal quarterly installments thereafter."}],"balance_after":7755,"derivative":{"exercise_price":70.64,"expiration_date":"2031-04-08","underlying":"Common Stock","underlying_shares":7755},"source":{"system":"sec-edgar","filing":"0001209191-21-026445","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919121026445/doc4.xml","form_type":"4"}},{"id":2750412,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-13T20:37:14.000Z","date":"2021-04-09","kind":"grant","acquired":true,"shares":4955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":4955,"source":{"system":"sec-edgar","filing":"0001209191-21-026445","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919121026445/doc4.xml","form_type":"4"}},{"id":2809021,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-04T22:48:16.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 2, 2021 and vests in three equal annual installments on the anniversary of the grant date, subject to continued service as a director, and in the event of a change in control, the vesting schedule of the option will accelerate in full."}],"balance_after":40000,"derivative":{"exercise_price":10.72,"expiration_date":"2031-03-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-017948","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919121017948/doc4.xml","form_type":"4"}},{"id":2929530,"issuer":{"id":127212,"kind":"organization","name":"ASPENTECH Corp","symbol":"AZPN"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-12-30T17:00:16.000Z","date":"2020-12-28","kind":"grant","acquired":true,"shares":303,"price":130.51,"value":39544.53,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option granted at the exercise price of $130.51 was fully vested on the date of grant."}],"balance_after":303,"derivative":{"exercise_price":130.51,"exercise_date":"2020-12-28","expiration_date":"2030-12-27","underlying":"Common Stock","underlying_shares":303},"source":{"system":"sec-edgar","filing":"0001127602-20-032588","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/929940/000112760220032588/form4.xml","form_type":"4"}},{"id":2929529,"issuer":{"id":127212,"kind":"organization","name":"ASPENTECH Corp","symbol":"AZPN"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-12-30T17:00:16.000Z","date":"2020-12-28","kind":"grant","acquired":true,"shares":154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Aspen Technology, Inc. common stock. The Restricted Stock units were fully vested on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Restricted Stock Units were received as a grant for no consideration."}],"balance_after":1773,"source":{"system":"sec-edgar","filing":"0001127602-20-032588","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/929940/000112760220032588/form4.xml","form_type":"4"}},{"id":3422332,"issuer":{"id":127212,"kind":"organization","name":"ASPENTECH Corp","symbol":"AZPN"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-09-05T16:40:11.000Z","date":"2019-09-03","kind":"grant","acquired":true,"shares":1444,"price":133.2,"value":192340.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option granted at the exercise price of $133.20 was fully vested on the date of grant."}],"balance_after":1444,"derivative":{"exercise_price":133.2,"exercise_date":"2019-09-03","expiration_date":"2029-09-02","underlying":"Common Stock","underlying_shares":1444},"source":{"system":"sec-edgar","filing":"0001127602-19-027997","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/929940/000112760219027997/form4.xml","form_type":"4"}},{"id":3422331,"issuer":{"id":127212,"kind":"organization","name":"ASPENTECH Corp","symbol":"AZPN"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-05T16:40:11.000Z","date":"2019-09-03","kind":"grant","acquired":true,"shares":732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Aspen Technology, Inc. common stock.  The Restricted Stock Units were fully vested on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Restricted Stock Units were received as a grant for no consideration."}],"balance_after":1619,"source":{"system":"sec-edgar","filing":"0001127602-19-027997","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/929940/000112760219027997/form4.xml","form_type":"4"}},{"id":3552295,"issuer":{"id":127212,"kind":"organization","name":"ASPENTECH Corp","symbol":"AZPN"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-04-19T16:17:34.000Z","date":"2019-04-17","kind":"grant","acquired":true,"shares":1684,"price":109.97,"value":185189.48,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One third of the option granted at the exercise price of $109.97 will vest on the first anniversary of the grant date and the remainder will vest in eight equal consecutive quarterly installments on the last business day of the quarter until fully vested."}],"balance_after":1684,"derivative":{"exercise_price":109.97,"expiration_date":"2029-04-16","underlying":"Common Stock","underlying_shares":1684},"source":{"system":"sec-edgar","filing":"0001127602-19-015919","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/929940/000112760219015919/form4.xml","form_type":"4"}},{"id":3552294,"issuer":{"id":127212,"kind":"organization","name":"ASPENTECH Corp","symbol":"AZPN"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-04-19T16:17:34.000Z","date":"2019-04-17","kind":"grant","acquired":true,"shares":887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Aspen Technology, Inc. common stock. One third of the Restricted Stock Units will vest on the first anniversary of the grant date, and the remainder will vest in eight equal consecutive quarterly installments on the last business day of the quarter until fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Restricted Stock Units were received as a grant for no consideration."}],"balance_after":887,"source":{"system":"sec-edgar","filing":"0001127602-19-015919","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/929940/000112760219015919/form4.xml","form_type":"4"}}]}